Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019 - 30/10/20
Doi : 10.1016/j.ajog.2020.08.001
Irogue Igbinosa, MD 
, Sarah Miller, MD, Katherine Bianco, MD
, Sarah Miller, MD, Katherine Bianco, MD Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Stanford University, Stanford, CA
Joanna Nelson, MD, Shanthi Kappagoda, MD, Brian G. Blackburn, MD, Philip Grant, MD, Aruna Subramanian, MD
Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA
Deirdre J. Lyell, MD, Yasser Y. El-Sayed, MD, Natali Aziz, MD, MS
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Stanford University, Stanford, CA
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Vol 223 - N° 5
P. 768-770 - novembre 2020 Retour au numéro
Article précédent
- Are clinical outcomes worse for pregnant women at ?20 weeks’ gestation infected with coronavirus disease 2019? A multicenter case-control study with propensity score matching
- Dominique A. Badr, Jérémie Mattern, Andrew Carlin, Anne-Gaël Cordier, Evelyne Maillart, Larissa El Hachem, Hanane El Kenz, Marc Andronikof, David De Bels, Charles Damoisel, Thierry Preseau, Dorothée Vignes, Mieke M. Cannie, Christelle Vauloup-Fellous, Jean-François Fils, Alexandra Benachi, Jacques C. Jani, Alexandre J. Vivanti
- Unintended consequences of the transition to telehealth for pregnancies complicated by opioid use disorder during the coronavirus disease 2019 pandemic
- Monique E. McKiever, Erin M. Cleary, Tonya Schmauder, Allison Talley, Katherine A. Hinely, Maged M. Costantine, Kara M. Rood
Bienvenue sur EM-consulte, la référence des professionnels de santé.